Free Trial

Cortexyme (CRTX) Insider Trading & Ownership

Cortexyme logo
$1.71 -0.05 (-2.84%)
(As of 12/24/2024 ET)

Cortexyme (NASDAQ:CRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
27.90%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$30,888.00
Get CRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cortexyme stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRTX Insider Buying and Selling by Quarter

Cortexyme Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2022Caryn Gordon McdowellInsiderSell10,800$2.86$30,888.00  
(Data available from 1/1/2013 forward)

CRTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cortexyme includes Caryn Gordon Mcdowell. Learn more on insiders at CRTX.

27.90% of Cortexyme stock is owned by insiders. Learn more on CRTX's insider holdings.

Cortexyme Key Executives

  • Dr. Leslie J. Holsinger Ph.D. (Age 57)
    Exec. VP of R&D
    Compensation: $603.85k
  • Dr. Dirk Thye M.D. (Age 52)
    CEO & Director
  • Mr. Ted Monohon (Age 56)
    VP of Fin., Principal Financial Officer & Chief Accounting Officer
  • Mr. Brendan Hannah M.B.A.
    Chief Bus. Officer
  • Dr. Karen L. Smith L.L.M (Age 54)
    L.L.M., M.B.A., M.D., PH.D., Chief Medical Officer


This page (NASDAQ:CRTX) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners